| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.03 |